Aminoalkoxy-substituted coumarins: Synthesis and evaluation for reactivation of inhibited human acetylcholinesterase

Arch Pharm (Weinheim). 2022 Nov;355(11):e2200208. doi: 10.1002/ardp.202200208. Epub 2022 Jul 25.

Abstract

Reactivation of inhibited acetylcholinesterase remains an important therapeutic strategy for the treatment of poisoning by organophosphorus compounds, such as nerve agents or pesticides. Although drugs like obidoxime or pralidoxime have been used with considerable success, there is a need for new substances capable of reactivating acetylcholinesterase with a broader scope and increased efficacy. Possible screening candidates must fulfill two fundamental requirements: They must (i) show an affinity to acetylcholinesterase well balanced between sufficient binding and competitive inhibition and (ii) facilitate the nucleophilic cleavage of the phosphorylated catalytic serine residue. We attached a variety of nonaromatic primary and secondary amines to a coumarin core through selected alkoxy side linkers attached at coumarin positions 6 or 7 to obtain a small set of possible reactivators. Evaluation of their inhibition and reactivation potential in vitro showed some activity with respect to acetylcholinesterase inhibited by cyclosarin.

Keywords: Mitsunobu reaction; acetylcholinesterase; coumarins; enzyme reactivation; organophosphorus compounds.

MeSH terms

  • Acetylcholinesterase* / metabolism
  • Cholinesterase Inhibitors / pharmacology
  • Cholinesterase Reactivators* / chemistry
  • Cholinesterase Reactivators* / pharmacology
  • Coumarins / pharmacology
  • Humans
  • Organophosphorus Compounds / pharmacology
  • Oximes / chemistry
  • Structure-Activity Relationship

Substances

  • Acetylcholinesterase
  • Cholinesterase Reactivators
  • Cholinesterase Inhibitors
  • Oximes
  • Organophosphorus Compounds
  • Coumarins

Grants and funding